Last reviewed · How we verify

NCT05296642: EIHDM

Exercise Induced Hypoalgesia Diabetes

Withdrawn NA Last updated 25 May 2022
What this trial tests

NA trial testing Moderate Cycling in Diabetic Peripheral Neuropathy. Withdrawn.

Timeline
1 August 2022
Primary endpoint
31 August 2023
31 August 2023

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposediagnostic
Start date1 August 2022
Primary completion31 August 2023
Estimated completion31 August 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 18 to 65, any sex, with Diabetic Peripheral Neuropathy or Diabetic Peripheral Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to learn whether different forms of exercise can reduce pain experienced by individuals with painful diabetic peripheral neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Peripheral Neuropathy

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05296642.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing